Stock Events

Stock Events

Eiger BioPharmaceuticals (EIGR) Q2 2023 Earnings

14AugConfirmed

Nov 22

Q4 2022

Q1 2023

Q2 2023

-0.62

-0.55

-0.48

-0.41

Details

Expected EPS

-0.41

Actual EPS

-0.47

Surprise EPS

-0.06

Surprise Percent

+14.63%

Description

Eiger BioPharmaceuticals (EIGR) has reported earnings of -0.47 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.